Argenica Therapeutics Limited (AGN.AX)
AUD 0.62
(-3.13%)
AUD 0.62
(-3.13%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 2.59 Million | 1.74 Million | 259.09 Thousand | 296.07 Thousand | - |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | 2.59 Million | 1.74 Million | 259.09 Thousand | 296.07 Thousand | - |
| Operating Expenses | 8.26 Million | 6.62 Million | 4.35 Million | 1.32 Million | 383.65 Thousand |
| Selling, General and Administrative Expenses | 2.25 Million | 2.31 Million | 1.74 Million | 789.66 Thousand | 50.66 Thousand |
| Research and Development Expenses | 6.01 Million | 4.3 Million | 2.49 Million | 416.04 Thousand | 332.98 Thousand |
| Other Expenses | - | 1.74 Million | 259.09 Thousand | 296.07 Thousand | - |
| Cost and Expenses | 8.26 Million | 6.62 Million | 4.35 Million | 1.32 Million | 383.65 Thousand |
| Operating Income | -5.67 Million | -6.62 Million | -4.08 Million | -1.02 Million | -383.65 Thousand |
| Interest Expense | - | 1050.00 | 822.00 | 20.00 | - |
| Income Tax Expense | -2.08 Million | -1.37 Million | -259.09 Thousand | 54.00 | -657.68 Thousand |
| Earnings before Tax | -7.56 Million | -6.19 Million | -4.09 Million | -1.02 Million | -383.4 Thousand |
| Net Income | -5.47 Million | -4.81 Million | -4.09 Million | -1.02 Million | -383.4 Thousand |
| Earnings Per Share Basic | -0.05 | -0.06 | -0.06 | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.05 | -0.06 | -0.06 | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 103.38 Million | 87.57 Million | 73.92 Million | 73.17 Million | 73.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 103.7 Million | 87.57 Million | 73.92 Million | 73.17 Million | 73.17 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | - |
| EBIT Margin | -0.73 | -3.79 | -15.79 | -3.48 | - |
| Profit Margin | -2.11 | -2.75 | -15.79 | -3.48 | - |
| EBITDA | -1.89 Million | - | - | - | - |
| Earnings Before Tax Margin | -2.18 | -3.79 | -15.79 | -3.48 | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | - | 122.75 Thousand | 122.75 Thousand | 1.17 Million | 1.17 Million | 1.74 Million |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | 122.75 Thousand | 122.75 Thousand | 1.17 Million | 1.17 Million | 1.74 Million |
| Operating Expenses | 8.26 Million | 2.22 Million | 2.22 Million | 3.81 Million | 1.9 Million | 6.62 Million |
| Selling, General and Administrative Expenses | - | 629.05 Thousand | 629.05 Thousand | 994.28 Thousand | 497.14 Thousand | - |
| Research and Development Expenses | - | 1.59 Million | 1.59 Million | 2.81 Million | 1.4 Million | - |
| Other Expenses | - | - | - | - | - | 1.74 Million |
| Cost and Expenses | 8.26 Million | 2.22 Million | 2.22 Million | 3.81 Million | 1.9 Million | 6.62 Million |
| Operating Income | -8.26 Million | -2.1 Million | -2.1 Million | -3.81 Million | -730.51 Thousand | -6.62 Million |
| Interest Expense | - | - | - | - | - | 1050.00 |
| Income Tax Expense | -2.08 Million | -4.45 Million | - | -2.12 Million | 25.73 Thousand | -1.37 Million |
| Earnings before Tax | -7.56 Million | -2.03 Million | -2.03 Million | -3.53 Million | -704.77 Thousand | -6.19 Million |
| Net Income | -5.47 Million | -2.03 Million | -2.03 Million | -1.4 Million | -704.77 Thousand | -4.81 Million |
| Earnings Per Share Basic | - | -0.02 | -0.02 | -0.01 | -0.01 | - |
| Earnings Per Share Diluted | - | -0.02 | -0.02 | -0.01 | -0.01 | - |
| Weighted Average Shares Outstanding | 103.7 Million | 107.7 Million | 107.7 Million | 99.15 Million | 99.26 Million | 87.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 103.7 Million | 108.14 Million | 108.14 Million | 99.15 Million | 99.26 Million | 87.57 Million |
| Gross Margin | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | -36.30 | - | -3.24 | 0.02 | - |
| Profit Margin | - | -16.58 | -16.58 | -1.20 | -0.60 | -2.75 |
| EBITDA | - | -4.45 Million | - | -3.81 Million | 25.73 Thousand | - |
| Earnings Before Tax Margin | - | -17.15 | -17.15 | -3.24 | -0.62 | -3.79 |
PCJEWELLER
131970
EMWPF
KOS
123690
OTCFF